Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β2
- 31 July 1993
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 46 (1-2) , 175-183
- https://doi.org/10.1016/0165-5728(93)90247-v
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- Transforming growth factors type β1 and β2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-γ and tumor necrosis factor-αJournal of Neuroimmunology, 1990
- Transforming growth factors β1 and β2: cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell functionJournal of Neuroimmunology, 1989
- Inflammatory and immunomodulatory roles of TGF-βImmunology Today, 1989
- Transforming growth factor-beta. Multiple actions and potential clinical applicationsJAMA, 1989
- Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cellsNature, 1987
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Transforming Growth Factor-β: Biological Function and Chemical StructureScience, 1986